DEC1 anticorps (AA 350-412)
Aperçu rapide pour DEC1 anticorps (AA 350-412) (ABIN2252137)
Antigène
Voir toutes DEC1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 350-412
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- DEC1 (DEC-1, Differentially Expressed in Chondrocytes, Differentiated Embryo Chrondrocyte Expressed Gene 1, BHLHB2, Basic Helix-Loop-Helix Domain Containing Class B 2, SHARP2, SHARP-2, STRA13, STRA14)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to a region between aa350-412 of the C-terminus of human DEC1 (Accession # NP_003661.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- 4°C ,Do Not Freeze
-
-
- DEC1 (Deleted in Esophageal Cancer 1 (DEC1))
-
Autre désignation
- DEC1
-
NCBI Accession
- NP_003661
Antigène
-